Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Promises from trametinib in RAF active tumors.

× No keyword cloud information.

3 in total

1. Therapeutic effects of targeting RAS-ERK signaling in giant congenital melanocytic nevi.

Authors: Qingxiong Yu; Min Wu; Lingling Sheng; Qingfeng Li; Feng Xie
Journal: Am J Transl Res Date: 2018-04-15 Impact factor: 4.060

2. Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction.

Authors: Pei Jye Voon; Eric X Chen; Helen X Chen; Albert C Lockhart; Solmaz Sahebjam; Karen Kelly; Ulka N Vaishampayan; Vivek Subbiah; Albiruni R Razak; Daniel J Renouf; Sebastien J Hotte; Arti Singh; Philippe L Bedard; Aaron R Hansen; S Percy Ivy; Lisa Wang; Lee-Anne Stayner; Lillian L Siu; Anna Spreafico
Journal: J Exp Clin Cancer Res Date: 2022-02-07

3. A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01.

Authors: Sébastien Perreault; Valérie Larouche; Uri Tabori; Cynthia Hawkin; Sarah Lippé; Benjamin Ellezam; Jean-Claude Décarie; Yves Théoret; Marie-Élaine Métras; Serge Sultan; Édith Cantin; Marie-Ève Routhier; Maxime Caru; Geneviève Legault; Éric Bouffet; Lucie Lafay-Cousin; Juliette Hukin; Craig Erker; Nada Jabado
Journal: BMC Cancer Date: 2019-12-27 Impact factor: 4.430

3 in total